We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Seeks to Clarify Formatting of ICSRs
Guidance Seeks to Clarify Formatting of ICSRs
July 30, 2013
The FDA wants drugmakers to fully understand that non-expedited individual case safety reports (ICSRs), filed alongside periodic adverse drug experience reports, shouldn’t be submitted in portable document format (PDF) but in extensive markup language (XML).